<span item_type="fundamental" item_id="c9aa72dde6eccab980d7a30c5c712e02" counter_id="ST/US/EXPO" env="prod"></span><span item_type="announcement" item_id="612875122309601665" env="prod"></span><p>Revenue: As of FY2027 Q4, the actual value is USD 147.43 M.</p><p>EPS: As of FY2027 Q4, the actual value is USD 0.49.</p><p>EBIT: As of FY2027 Q4, the actual value is USD 27.2 M.</p><p></p><h3>Fourth Quarter Fiscal Year 2025 Financial Results (13 weeks ended January 2, 2026, compared to 14 weeks ended January 3, 2025)</h3><h4>Revenue</h4><ul><li>Total revenues increased 7.8% to $147.4 million, up from $136.8 million in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>Revenues before reimbursements increased 4.5% to $129.4 million, up from $123.8 million in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Net Income</h4><ul><li>Net income increased to $24.8 million, compared to $23.6 million in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Operating Profit and Margin</h4><ul><li>Operating income was $29.14 million, compared to $27.253 million in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>EBITDA increased to $34.7 million, or 26.8% of revenues before reimbursements, compared to $31.2 million, or 25.2% of revenues before reimbursements, in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Operating Costs</h4><ul><li>Total operating expenses were $118.285 million, compared to $109.513 million in the prior year period. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Segment Performance</h4><ul><li>The Engineering and Other Scientific segment represented 85% of revenues before reimbursements, with revenues before reimbursements increasing 7%. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>The Environmental and Health segment represented 15% of revenues before reimbursements, with revenues before reimbursements decreasing 5%. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h3>Fiscal Year 2025 Financial Results (52 weeks ended January 2, 2026, compared to 53 weeks ended January 3, 2025)</h3><h4>Revenue</h4><ul><li>Total revenues increased 4.2% to $582.0 million, up from $558.5 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>Revenues before reimbursements increased 3.5% to $536.8 million, up from $518.5 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Net Income</h4><ul><li>Net income was $106.0 million, compared to $109.0 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Operating Profit and Margin</h4><ul><li>Operating income was $119.787 million, compared to $119.557 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>EBITDA increased to $148.1 million, or 27.6% of revenues before reimbursements, compared to $147.1 million, or 28.4% of revenues before reimbursements, in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Operating Costs</h4><ul><li>Total operating expenses were $462.227 million, compared to $438.957 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Cash Flow and Capital Allocation</h4><ul><li>毅博科技咨询 (Exponent, Inc.) paid $61.5 million in dividends during fiscal year 2025. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>The company repurchased $97.8 million of common stock during fiscal year 2025. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>毅博科技咨询 (Exponent, Inc.) ended the year with $221.9 million in cash and cash equivalents, compared to $258.901 million in the prior year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Operational Metrics</h4><ul><li>Headcount increased sequentially and was up approximately 4% for the year. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>Fourth quarter utilization improved on a year-over-year basis. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Segment Performance</h4><ul><li>The Engineering and Other Scientific segment represented 84% of revenues before reimbursements, with revenues before reimbursements increasing 4%. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>The Environmental and Health segment represented 16% of revenues before reimbursements, with revenues before reimbursements being approximately flat. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li></ul><h4>Dividends</h4><ul><li>毅博科技咨询 (Exponent, Inc.) increased its quarterly cash dividend from $0.30 to $0.31 per share of common stock for Q1 2026. <span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_992.htm"></span></li><li>This quarterly cash dividend of $0.31 per share is scheduled to be paid on March 20, 2026, to all common stockholders of record as of March 6, 2026. <span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_992.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="3" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/f8k_020526.htm"></span></li></ul><h4>Business Outlook</h4><ul><li>For the first quarter of fiscal year 2026, 毅博科技咨询 (Exponent, Inc.) anticipates revenues before reimbursements to grow in the high-single digits and EBITDA to be 27.5% to 28.5% of revenues before reimbursements. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>For the full fiscal year 2026, the company expects revenues before reimbursements to grow in the high-single digits and EBITDA to be 27.6% to 28.1% of revenues before reimbursements. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span></li><li>Management expressed confidence in continued profitable growth, supported by strong market drivers and the company’s operating model, and expects to continue paying quarterly dividends. <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_991.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/851520/000117184326000654/exh_992.htm"></span></li></ul>

Exponent | 8-K: FY2027 Q4 Revenue: USD 147.43 M